New study finds counterproductive effect of Parkinson's disease drug
The drug can disrupt the gut microbiome in a way that hinders the efficacy of levodopa, a Parkinson's disease treatment that increases dopamine in the brain.
The drug can disrupt the gut microbiome in a way that hinders the efficacy of levodopa, a Parkinson's disease treatment that increases dopamine in the brain.